Association between proprotein convertase subtilisin/kexin type 9 and subclinical cerebrovascular disease in the community.
Ayako KunimuraYuichiro YanoTakashi HisamatsuSayuki ToriiKeiko KondoAya KadotaAkira FujiyoshiTomonori OkamuraYoshiyuki WatanabeAkihiko ShiinoKazuhiko NozakiHirotsugu UeshimaKatsuyuki Miuranull nullPublished in: European journal of neurology (2023)
Higher circulating PCSK9 levels were independently associated with an ICAS prevalence but not with CSVD prevalence. The quantification of circulating PCSK9 levels may help to identify individuals at high risk for cerebrovascular disease in the general population.